Chronic Obstructive Pulmonary Disease (COPD) is a long-term, inflammatory lung condition that causes airflow obstruction and reduced lung function. In short, COPD makes it hard to breathe.

The pulmonary emphysema market is poised for steady growth driven by rising COPD prevalence, an aging global population, and greater diagnostic awareness. Advances in inhaled therapies, targeted ...

Chronic obstructive pulmonary disease is a condition caused by damage to the lungs that results in breathing difficulties.

Men and women with chronic obstructive pulmonary disease (COPD), bronchiectasis, and nontuberculous mycobacterial (NTM) lung ...

COPD research needs to increase focus on rural health disparities and consider the impact of sociocultural and environmental ...

COPD research needs to increase focus on rural health disparities and consider the impact of sociocultural and environmental exposures on health outcomes, according to a new perspective in the ...

COPD is a group of lung diseases that get worse over time. It prevents airflow to the lungs, causing breathing problems and ...

CHICAGO — Hospital volume affected the length of stay for patients with COPD who elect to have endobronchial valve placement, with some association with costs as well, according to an abstract ...

Staged LVRS offered similar hospital length of stay and complication rates as bilateral LVRS. Both approaches led to clinically significant improvements in pulmonary function. Notably, the staged ...

Objectives There is a lack of knowledge about whether occupational exposures increase the risk of emphysema, especially in ...

THE NHS has issued a plea for people with chronic obstructive pulmonary disease (COPD) to follow three simple steps to protect their lungs ...

Regardless of blood eosinophil count threshold, adults with COPD and an eosinophilic phenotype experienced significantly fewer moderate/severe exacerbations in a year with mepolizumab vs. placebo, ...